GlyCare™

Available for use in more than 125 countries

Stamps of approval

Largest global market access

GlyCare™ 2FL and GlyCare™ LNnT have approvals for use in the EU, and have notified GRAS status in the US, along with independent approvals for many countries in Asia, South America and Africa.

Products containing our HMOs are available in more than 125 countries and we are continuously expanding our global approval footprint across application areas. 

GlyCare™ Products

Human Milk Oligosaccharides portfolio

Learn more